AAV Rapid Quantitation Kit

  • Ultra-fast procedure (<2 hours)
  • Measures the viral nucleic acid content of unpurified AAV-2 or AAV-DJ supernatant or purified AAV of any serotype
  • Limit of detection: 10^9 GC/mL from unpurified AAV supernatant or 5 x 10^10 GC/mL for purified AAV

 

Frequently Asked Questions about this product

General FAQs about using AAV

General FAQs about Viral Gene Delivery

Email To BuyerPrint this PageCopy Link
Ordering

Please contact your distributor for pricing.

QuickTiter™ AAV Quantitation Kit
Catalog Number
VPK-145
Size
20 assays
Detection
Fluorometric
Manual/Data Sheet Download
SDS Download
Price
$570.00
QuickTiter™ AAV Quantitation Kit, Trial Size
Catalog Number
VPK-145-T
Size
4 assays
Detection
Fluorometric
Manual/Data Sheet Download
SDS Download
Price
$285.00
Product Details

Traditionally, adeno-associated virus (AAV) particles have been quantified by DNA dot blot or similar procedures. These methods can be time-consuming and suffer from a high degree of inter-assay variability.

Our QuickTiter™ AAV Quantitation Kit uses a proprietary technology to quantify the viral nucleic acid content of AAV preps. The kit can be used with unpurified supernatant of AAV-2 or AAV-DJ, or with purified AAV from any serotype.

Assay Principle for the QuickTiter™ AAV Quantitation Kit.

Standard Curve Generated with the QuickTiter™ AAV Quantitation Kit.The QuickTiter™ AAV-2 DNA Standard was diluted as described in the Assay Protocol. Fluorescence measurement was performed on a SpectraMax Gemini XS Fluorometer (Molecular Devices) with a 485/538 nm filter set and 530 nm cutoff.

Recent Product Citations
  1. Tseng, S.J. et al. (2016). Remote control of light-triggered virotherapy. ACS Nano 10:10339-10346.
  2. Eliava, M. et al. (2016). A new population of parvocellular oxytocin neurons controlling magnocellular neuron activity and inflammatory pain processing. Neuron 89:1291-1304.
  3. Madroñal, N. et al. (2016). Rapid erasure of hippocampal memory following inhibition of dentate gyrus granule cells. Nat Commun. doi:10.1038/ncomms10923.
  4. Park, H. Y. et al. (2016). Gadd45β ameliorates L-DOPA-induced dyskinesia in a Parkinson's disease mouse model. Neurobiol Dis. 89:169-179.
  5. Tran, L. & Keele, N. B. (2016). CaMKIIα knockdown decreases anxiety in the open field and low serotonin-induced upregulation of GluA1 in the basolateral amygdala. Behav Brain Res. 303:152-159.
  6. Chen, W. et al. (2016). The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation. J Periodontal Res.doi:10.1111/jre.12345.
  7. Orabi, A. I. et al. (2015). Dynamic imaging of pancreatic NF-κB activation in live mice using AAV infusion and bioluminescence. J Biol Chem. doi:10.1074/jbc.M115.647933.
  8. Oh, S. M. et al. (2015). Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease. EMBO Mol Med. doi: 10.15252/emmm.201404610. 
  9. Stankowska, D. L. et al. (2015). Neuroprotective effects of transcription factor brn3b in an ocular hypertension rat model of glaucoma. Invest Ophthalmol Vis Sci.  doi: 10.1167/iovs.14-15008.
  10. Li, Y. et al. (2014). Assembly and Validation of Versatile Transcription Activator-Like Effector Libraries. Sci Rep. 4:4857.
  11. Paydar, A. et al. (2014). Extrasynaptic GABAA Receptors in Mediodorsal Thalamic Nucleus Modulate Fear Extinction Learning. Mol Brain. 7:39.
  12. Vinnikov, I. A. et al. (2014). Hypothalamic miR-103 Protects from Hyperphagic Obesity in Mice.J Neurosci. 34:10659-10674.
  13. Ma, J. et al. (2013). RNA Interference-Mediated Silencing of Atp6i Prevents Both Periapical Bone Erosion and Inflammation in the Mouse Model of Endodontic Disease. Infect. Immun. 81:1021-1030.
  14. Tao, P. et al. (2013). In Vitro and In Vivo Delivery of Genes and Proteins Using the Bacteriophage T4 DNA Packaging Machine. PNAS 10.1073/pnas.1300867110.